Basak A, Boudreault A, Chen A, Chrétien M, Seidah N G, Lazure C
Neuropeptides Structure and Metabolism Laboratory, Clinical Research Institute of Montréal, Québec, Canada.
J Pept Sci. 1995 Nov-Dec;1(6):385-95. doi: 10.1002/psc.310010606.
Antiserum against an N-terminal sequence of murine prohormone convertase-1 (mPC1) incorporating the sequence immediately following the junction between the putative pro-region and the active enzyme was obtained. This was accomplished using the multiple antigenic peptide (MAP) approach whereupon an 8-branched polylysine core to which are grafted multiple copies of a 16 amino acid peptide representing the N-terminal sequence of mPC1 (positions 84-99) was synthesized by solid-phase Fmoc chemistry. The ensuing peptide was purified and fully characterized by RP-HPLC, 1H-NMR, amino acid composition, peptide sequencing and ion-spray mass spectrometry. The immunological properties of the resulting antibodies in detecting recombinant PC1 in both crude and purified preparations were compared with antibodies raised against a similar N-terminal segment of PC1 but using the conventional method of peptide-carrier protein conjugation and also developed against a C-terminal fusion protein of PC1. Our data indicate that the MAP antibody was as efficient as both the amino and carboxy-terminal antibodies in qualitative as well as quantitative analysis of PC1 encoded protein by radioimmunoassay. Following an identical approach, antibodies against other prohormone convertases like furin, PC5/6 and PACE4 were also developed and subsequently applied to a number of biochemical and immunological studies. In each case, the case of preparation and high immunogenicity of the MAP approach were confirmed and reside in the simplicity and rapidity with which a potent and useful antiserum is obtained.
获得了针对小鼠激素原转化酶-1(mPC1)N端序列的抗血清,该序列包含假定的前体区域与活性酶之间连接点之后的序列。这是通过多抗原肽(MAP)方法实现的,据此通过固相Fmoc化学合成了一个8分支的聚赖氨酸核心,在该核心上接枝了多个代表mPC1 N端序列(第84 - 99位)的16氨基酸肽拷贝。随后对所得肽进行纯化,并通过反相高效液相色谱(RP-HPLC)、1H-核磁共振(1H-NMR)、氨基酸组成、肽测序和离子喷雾质谱对其进行全面表征。将所得抗体在检测粗制和纯化制剂中的重组PC1时的免疫特性,与针对PC1类似N端片段但使用肽-载体蛋白偶联的传统方法制备的抗体以及针对PC1 C端融合蛋白制备的抗体进行了比较。我们的数据表明,在通过放射免疫分析对PC1编码蛋白进行定性和定量分析时,MAP抗体与氨基端和羧基端抗体一样有效。按照相同的方法,还制备了针对其他激素原转化酶如弗林蛋白酶、PC5/6和PACE4的抗体,并随后应用于多项生化和免疫学研究。在每种情况下,都证实了MAP方法制备简单且免疫原性高,其优点在于能够简便快速地获得高效且有用的抗血清。